Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma
Alfredo Gorio(University of Milan), Michael Brines(Northwell Health), Serhat Erbayraktar(University of Messina), Laura Madaschi(University of Milan), Anna Maria Di Giulio(University of Milan), Necati Gökmen(University of Messina), Anthony Cerami(Araim Pharmaceuticals (United States)), Enver Vardar(University of Milan), Osman Yılmaz(University of Messina), Cinzia Cichetti(University of Milan)
Cited by 392
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
|Proceedings of the National Academy of Sciences|2004|654